Welcome to our dedicated page for Keysight Technologies SEC filings (Ticker: KEYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keysight Technologies filings document the regulatory record for an NYSE-listed test and measurement technology company with common stock trading under KEYS. Recent Form 8-K reports cover quarterly and fiscal-year financial results, non-GAAP reconciliations, investor presentations related to acquisitions, and material financing arrangements.
The company’s proxy and annual-meeting disclosures address director elections, auditor ratification, executive compensation votes, board structure, stockholder proposals and governance matters. Other current reports document board appointments, executive transitions, credit-agreement terms, revolving-credit capacity, covenant requirements and related capital-structure obligations.
Keysight Technologies (KEYS) SVP Ingrid A. Estrada reported a significant insider transaction on Form 4. On June 20, 2025, Estrada sold 10,000 shares of common stock at an average weighted price of $158.9682 per share (ranging from $158.145 to $159.657).
Following the transaction, Estrada continues to directly own 108,590.19 shares of Keysight Technologies common stock. The sale was executed through multiple trades and was reported via attorney-in-fact Jeffrey K. Li on June 24, 2025.
This insider sale by a senior executive represents a notable disposition of shares, though Estrada maintains a substantial position in the company. The transaction was conducted in compliance with SEC regulations and disclosure requirements under Section 16(a) of the Securities Exchange Act of 1934.
Keysight Technologies, Inc. (KEYS) has filed a Form 144 notice indicating a proposed insider sale. The filing discloses that an unnamed affiliate intends to sell 10,000 common shares through Fidelity Brokerage Services LLC on or about 20 June 2025. Based on the filing’s reference price, the transaction represents an aggregate market value of $1,589,682.42.
The planned sale equates to roughly 0.006 % of Keysight’s 172,108,859 shares outstanding and arises from multiple tranches of restricted-stock vesting awards received between November 2020 and November 2021. The filer reports no share sales during the past three months and certifies there is no undisclosed material adverse information. Other standard Form 144 sections—filer identity, relationship to issuer, and remarks—were left blank in the submission.
Because Form 144 merely gives advance notice rather than confirming execution, investors should view the filing as a preliminary intent to sell rather than a completed transaction. The modest size relative to float suggests limited direct market impact, though it can still signal personal diversification or liquidity needs by the insider.